| Literature DB >> 27061932 |
Maria Ilaria Del Principe1, Loredana Sarmati2, Mariagiovanna Cefalo1, Carla Fontana3, Giovanna De Santis1, Francesco Buccisano1, Luca Maurillo1, Eleonora De Bellis1, Massimiliano Postorino1, Giuseppe Sconocchia4, Giovanni Del Poeta1, Maurizio Sanguinetti5, Sergio Amadori1, Livio Pagano6, Adriano Venditti1.
Abstract
Invasive fungal infections, usually Aspergillus and Candida, represent a major cause of morbidity and mortality in patients with malignant haematological diseases, but in the last years rare fungal infections have more frequently been reported. Here, we report the clinical history of three patients affected with haematological malignancies who developed an infection caused by Geotrichum (G.) clavatum. Two out of three patients were affected by acute myeloid leukaemia (AML), and one by mantle cell lymphoma (MCL). All patients received cytarabine-based chemotherapeutic regimens and developed G. clavatum infection within 3 weeks from therapy initiation. In all cases, G. clavatum was isolated from central venous catheter and peripheral blood cultures. In vitro susceptibility test confirmed an intrinsic resistance to echinocandins and, in all cases, visceral localisations (spleen, liver and lung) were documented by total body computed tomography (CT) scan. A prolonged antifungal therapy with high doses liposomal amphotericin-B was necessary to obtain fever resolution. Only the patient with MCL died while the other two AML recovered, and one of them after received an allogeneic stem cell transplantation. We consecutively reviewed all published cases of infection caused by G. clavatum. Our experience and literature review indicate that G. clavatum can cause invasive infection in haematological patients, mainly in those with acute leukaemia.Entities:
Keywords: (1→3)-β-d-glucan; Geotrichum clavatum; acute myeloid leukaemia; emerging yeast infections; fungaemia; liposomal amphotericin-B; susceptibility tests
Mesh:
Substances:
Year: 2016 PMID: 27061932 DOI: 10.1111/myc.12508
Source DB: PubMed Journal: Mycoses ISSN: 0933-7407 Impact factor: 4.377